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S pCo) . , 
Under,9rqol. 
-rhes is Abstract 
LP ;;. It! q Guardian caregivers of pediatric oncology patients who have been treated with 
.2, ' 
~O~~hematoPoietic stem cell transplantatiori' (HSCT) are at risk for caregiver role strain and 
burden. This paper prese~ts a re~earch proposal for nurses interested in exploring 
.. caregiver role strain and burden in this population. A convenience sample often 
guardian sets of pediatric oncology patients who have been treated with HSCT should be 
utilized. Methodology will consist of interviews of caregivers for background 
information (Form 1); using open-ended questions and therapeutic conversation (Table 
1); and using the Marwit-Meuser Caregiver GriefInventory Childhood Cancer (MM-CGI 
Childhood Cancer). Data will help nurses identify areas of caregivers' lives that are 
affected during their child's treatment as well as the degree of grief they are 
experiencing. With this information, nurses can then develop interventions to help 
reduce the specific areas of burden and decrease a caregiver's degree of role strain. 
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CHAPTER I 
Introduction 
Cancer is a group of diseases of multiple causations characterized by defective 
cell growth and differentiation (Lewis, Heitkemper, Dirksen, O'Brien, & Bucher, 2007). 
The human body has a predetermined number of undifferentiated stem cells that 
ultimately differentiate into the various functioning cells that make up tissues within the 
body. The mature cells of each tissue then function as appropriate for the tissue type 
until they eventually degenerate and die as part of the natural life cycle of the cell. 
6 
An intracellular mechanism triggers cell growth, where, under normal conditions, 
cell growth equals cell degeneration maintaining equilibrium (Lewis et aI., 2007).· 
Cellular degeneration and cell death or a physiologic need activate cellular proliferation 
and growth. As an example, an increase in thrombocyte proliferation may be triggered 
by trauma or bleeding. Contact inhibition, or cells' tendency to stop growing when they 
come in contact with another cell, is another mechanism that controls cell proliferation. 
Normal function of the intracellular mechanism controlling proliferation is lost 
when a mutation occurs in the stem cell. One of three events can occur when a stem cell 
mutates: cellular death from damage or apoptosis, recognition of the mutation that signals 
repair, or survival wlth resultant passing along of the mutation to its d~lUghter cells 
(Lewis et aI., 2007). In the third scenario, these daughter cells are at risk of becoming 
malignant, though cancer may develop from normal tissue cells as well. 
Cellular differentiation also may be affected iq cancer, In normal healthy cells, 
cellular differentiation involves a specific progressive process of cellular maturation into 
the specific functioning cells of a given tissue. Under normal conditions, cells are not 
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able to regress to an undifferentiated state. During the maturation process, mutation may 
occur in protooncogenes, genes that regulate cell processes, or tumor suppressor genes, 
genes that regulate cell growth, causing disruption in the differentiation and proliferation 
cycles of the cell (Lewis et aI., 2007). For example, when mutation occurs in the 
',,': 
protooncbg~he, as may occur in exposure to carcinogens, cells gain the ability to revert 
back to their fetal, less differentiated, characteristics and appearance. 
Additionally, proliferation of malignant cells tends to follow the same rate of 
proliferation as'the cell type from which it originated, but the growth is continuous arid 
breaks the normal rules of equilibrium and contact inhibition. Malignant cells grow 
without regard to cell degeneration and physiologic need, and they can grow on top of 
one another as well as on t()P of and between other healthy cells. Irregular growth and 
unpredictable distribution throughout the body creates major challenges when trying to 
treat cancer (Lewis et aI., 2007). 
According to Lewis et iiI. (2007), the goal of cancer treatment is cure, control, or 
palliation~ The goal is determined by tumor cell type, location, size~ and systemic 
metastasis. The most common cancer treatments are surgery, chemotherapy, radiation 
, ' 
therapy, biologic and targeted therapy, arid hematopoietic stem cell transplantation ) 
(HSCT). Surgical therapy may be used to reduce the risk of cancer development in 
patierits: with predisposing 'coriditi()ns or as a cure for' a'localized tumor. It also may be 
used as an'adjuvant to other therapies; as a cytoreductive measure; or for creation of 
colostomies, insertion of gastric tubes, and placement of venous access devices (Lewis et 
aI., 2007). With any surgery comes the risk of complications such as infection, bleeding, 
and respiratory impairments. Surgery also requires recovery time, the length and rigor of 
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which depends on the procedure. Surgical procedures may also require a change in 
lifestyle, such as the patient who requires a permanent colostomy following a bowel 
resection from colon cancer. 
Chemotherapy involves the use of chemIcal agents as a form of systemic 
treatment for cancer. The goal of thi~ treatment is to reduce or eliminate the number of 
malignant cells in the body. Cell cycle phase nonspecific chemotherapeutic drugs affect 
all cells - malignant and normal- during all phases of the cell cycle. Cell.cycle phase-
specific chemotherapeutic drugs affect all cells during a specific phase in the cell cycle, 
such as during replication (Lewis et aI., 2007). These drugs are often used in tandem to 
. maximize the effects of the agents. Because systemic chemotherapy fails to distinguish 
between normal and rrialign~t ·cells, several side effects result from damaging healthy 
cells. These effects are classified as acute, delayed, or chromc. According to Lewis et aI. 
(2007), acute toxicity results in anaphylactic and hypersensitivity reactions, cardiac· 
dysrhythmias, and extravasation. Delayed effects include but are not limited to alopecia, 
nausea and vomiting, myelosuppression, anorexia, mucositis, skin reactions, diarrhea, 
constipation, fatigue, reproduCtive changes, central nervous system changes, and 
peripheral neuropathy. Chronic effects include lon·g-term damage to such organs as the 
lungs, heart, liver, and kidneys. Patients who have received cheniotherapy also may be at 
risk of developing secondary cancers. 
Radiation therapy involves the di~tribution and emiss.ion of energy into tissues to 
, . .. -
break chemical bonds in DNA. Lethal damage to cellular DNA results in the prevention 
of replication and impairs the protein synthesis essential for survival of the cell (Lewis et 
aI.,2007). Sublet?al damage may not result in immediate cell death, but may ultimately 
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lead to death through toxic accumulating effects. Because radiation therapy focuses 
energy to a localized field, it is not appropriate for systemic treatment, though it may be 
used as an adjuvant to other therapies that are systemic. Side effects of radiation therapy 
may include but are not limited to burns to the skin arid tissue irradiated, damage to 
organs irradiated (i.e. radiation to the pelvis may lead to infertility in females), fatigue, 
mucositis, nausea and vomiting, alopecia in radiation to the scalp, myelosuppression, 
anorexia, and risk of developing secondary cancers. 
Biologic therapy modifies the host-tumor response by having direct antitumor 
effects, changing the immune system response to the tumor, or acting upon the tumor 
cells' ability to proliferate or differentiate. Targeted therapy involves targeting specific 
cellular pathways and receptors in tumor growth and may include tyrosine kinase' 
inhibitors,monoclonal antibodies, vascular endothelial growth factor receptor inhibitors, 
and proteasome inhibitors (Lewis et aI., 2007). The administration of each of these 
therapies may lead to the endogenous release of other internal biologic agents, resulting 
in inflammatory and imrriune responses. Side effects of biologic and targeted therapies 
consist of nausea"anorexia, fatigue, headache, chills, myalgia, weakness, 
photosensitivity, diarrhea, and urticaria. Some agents may cause capillary leak 
syndrome, which can cause tachycardia, hypotension, and pulmonary edema. 
In patients with'ceitain cancers that do not respond to conventional chemotherapy 
dosing, radiation therapy, or who have relapsed, hematopoietic stem cell transplantation 
may be an option. Hematopoietic stem cell transplantation (HSCT) is a treatment used 
for both malignant and nonmalignant conditions and aliows for the safe use of high-dose 
chemotherapy with or without radiation therapy. The term hematopoietic stem cell 
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transplantation is the general terril replacing referen~e to bpne marrow transplantation, 
where stem cells are obtained from the bone marrow, and peripheral stem cells 
transplantation, where stem cells are obtained from the peripheral blood. The goal of 
HSCT is cure (Lewis et aI., 2007}. 
10 
HSCT involves eradication of cancer cells and the engraftment of stem cells. The 
patient is treated with doses of chemotherapy that would be dangerous without stem cell 
recovery due to pancytopenia and other effects with or without radiation therapy. Once 
the tumor cells are eliminated and remaining bone marrow is destroyed, the patient is 
infused with stem cells to produce new blood cells. In allogeneic transplantation, donor 
cells are tested· and determined a match for human leukocyte antigen (HLA) tissue typing 
to ensure compatibility of the transplanted cells. Donors are often family members, 
though donors may also beuirrelated and found through national registries (National 
Marrow Donor Program, 2010). Indications for allogeneic transplantation in oncologic 
conditions children may include acute myeloid leukemia, chronic myeloid leukemia, 
second remission or high-risk acute lyinphoblastic leukemia; and relapsed or high-risk 
non-Hodgkin's'lymphoma (Schmidt-Pokorny, 2009). 
Some conditions warrant treatment through autologous transplantation, where the 
patient receives his or her own stein cells after rec~iving myeloablative chemotherapy. 
Once the cells are obtained from the patient, they are treated to ptirge any malignant cells 
. . 
before transplantation back to the patient. Indications for autologous 'transplantation in 
the pediatric oncology population may include relapsed Hodgkin's lymphoma, advanced 
neuroblastoma, and r"elapsed or advanced solid turnors(Schmidf .. Pokorny, 2009). 
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Regardless_ of whether the transplant is allogeneic or- autologous, HSCT is 
associated with significant morbidity cind mortality (Hockenberry & Wilson, 2009). For 
example, with allogeneic transplantation, thougq there is also an increased possibility that 
the_ donor's cells m~y attack any ~alignant cells in the recipient, there IS also all increased 
risk of graft-versus,.host (GVH) disease, a potentially serious condition where the donor 
cells attack the recipient. Symptoms of GVH may begin seven to thirty days post-
transplant and include maculopapular rash beginning in the palms and soles of the feet 
and possibly leading to generalized erythema and desquamation, liver disease beginning 
as mild jaundice with the potential to become as serious as hepatic coma, and 
gastrointestinal distress ranging from diarrhea and abdominal cramping to bleeding and 
malabsorption. InfeCtion is of paramount concern because the patient's immune system 
is still weak and the treatment includes further immuriosuppression: In patients who do 
not experience GVH, infection is still a major concern post-transplant until the cells begin 
to proliferate and differentiate into a mature immune system, which usually takes two to 
four ~eeks (Lewis et aI., 2007). -
Given the significance of the malignant conditions, therapies, and treatment side 
effects, caregiver role strain and burden is common in guardian caregivers of patients 
with cancer. Guardian caregivers of pediatric oncology patients either who have 
undergone HSCT are at a particularly high risk of developing caregiver role strain and 
subjective and objective burden because their children are in the hospital for at least four 
weeks following transplant and require-meticulous infection control measures and careful 
observation for GVH. In addition to the acute worries of their child's condition, the 
guardian caregivers must balance the needs of their other children, personal health, 
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finances, work, and their personal relationships (Blanchard, Albrecht, & Ruckdeschel, 
1997). They also must considet'the long -term effects of transplantation and 
chemotherapy and/or radiation therapy .on their children, which may include secondary 
malignancies, organ damage, infertility, and neurological changes (Hockenberry & 
Wilson, 2009; Lewis et ai., 2007). 
Background and Significance 
12 
According to the American Cancer Society (2009), there were an estimated 
559,8888 cancer-related deaths in the United States in 2009, making it the second-leading 
cause of death behind heart disease in the United States. Though the risk of cancer 
·increases with age, cancer affects all sexes,ethnicities, and age groups. Cancers of the 
lung and bronchus are by far most fatal types of cancet in both men and women, causing 
30% of cancer-related deaths in men and 26% of cancer-related deaths in women .. 
(American Cancer Society, 2009). Although cancer remains a leading cause of death in 
America, cancer death rates have decreased 16% from 1991 to 2006. This is largely due 
to an increased focus on prevention and early detection . 
. Cancer is the second-leading cause of death in children ages one to fourteen years 
behind accidents in the United States (lemal, Siegel, Ward, Hao, Xu, & Thun, 2009). 
Sixteen in 100,000 children and teens were diagnosed with cancer.in 2006, and three in 
100,000 died as a result of disease or treatment (U.S. Cancer Statistics Working Group, 
2010). The most common childhood cancers were leukemia and brain and other nervous 
system cancers, with 4.3 out of every 100,000 people under twenty years diagnosed with 
leukemia in 2006 and three of every 100,000 people under twenty years qiagnosed with a 
nervous system cancer in 2006 (U.S. Cancer.Statistics Working Group, 2010). Also in 
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2006,0.7 of every 100,000 people under 20 died of leukemia whereas 0.6 of every 
100,000 people under 20 died of a central nervous system cancer (U.S. Cancer Statistics 
Working Group, 2010). Despite the fact that cancer is a leading cause of death among 
children, deaths associated with childhood cancer are declining due to an improvement in 
treatments in the past twenty-five years(Centers for Disease Control and Prevention; . 
2007). HSCT has provided a treatment for high-risk and relapsed cancers that do not 
respond to chemotherapy, and according to Schmidt-Pokorny (2009), twenty to twenty-
five percent ofHSCT in North America are performed on children. The five-year 
survival rate for all childhood cancer sites was 80% for those diagnosed in 1996-2004 
compared with 58% in those diagnosed in 1975-1977 (Jemal et aI., 2009). 
However, although treatments are improvirig and cancer deaths are decreasing 
among children, it remain·s a·leading cause of mortality in children arid a significant 
source of stress for their guardiancaregivers (AI-Gamal, Long, & Livesley, 2009; Ow, 
2003). This study will serve to identify specific stressors that caregivers of pediatric 
oncology patients who have undergone HSCT experience and explore the role strain 
placed on these guardian caregivers . 
. Statement of Problem 
HSCT is associated with significant morbidity and mortality (Hockenberry & 
Wilson, 2009). Due to the !lature of the treatment and acuity of the diseases that it treats, 
guardian caregivers of p~diatric oncology patients treated with HSCT are at risk for 
developing caregiver role strain and burden (Herdman (Ed.), 2009). 
RUNNING HEAD: Caregiver Strain Burden in Parents 
Statement of Purpose 
14 
The purpose of this study is to explore caregiver role strain and burden in 
guardian caregivers of pediatric oncology patients who have undergone or are waiting to 
undergo hematopoietic stem cell transplantation. 
Research Questions 
This study will provide answers to the following research questions: 
• To what degree do guardian caregivers fed as though the caregiver role has resulted 
in personal sacrifice burden? Heartfelt sadness and longing? Worry and isolation? 
• What is the total grief level of guardian caregivers? 
• What specific stressors has HSCT placed on the guardian caregivers? Family? 
• How has HSCT affeCted personal relationships within the family? Roles within the 
family? 
Theoretical Framework 
Lazarus arid Folkman (1984) suggest that coping is an ongoing dynamic process 
that involves cognitive and behavioral forces to manage external and/or internal demands 
placed on an individuaL The guardian caregiver of a pediatric oncology patient treated 
with HSCT is at risk for significant stress and role strain related to external and internal 
stressors (Herdman (Ed.), 2009). This theory will be used as the framework to explore 
caregivers' stressors throughout the study. 
Definition of Terms: Conceptual Definitions 
Caregiver Role Strain: According to NANDA International nursing diagnoses: 
Definitions and classification 2009-2011 (2009), caregiver role strain is in Domain 7: 
Role Relationships, Class I: Caregiving Roles of nursing diagnoses and is defined as 
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"difficulty in performing family caregiver role" (Herdman (Ed.), 2009; p. 201). The 
defining characteristics include difficulty and apprehension about caregiving activities; 
physical, emotional, and socioeconomic effects on caregiver health; and effects on the 
caregiver-care receiver relationship. Related factors include the health status of the care 
receiver, the health status ofthe caregiver, the relationship between the caregiver and the 
care receiver, activities involved in care giving, family processes, resources, and 
socioeconomic considerations (Herdman (Ed.), 2009). 
Caregiver subjective burden: The subjective burden of care is the psychological 
distress experienced by caregivers (Fadden, Bebbington, & Kuipers, 1987; Ow, 2003). 
This may include grief, a sense of loss, anxiety, or depression. 
" " 
Caregiver objective burden: The objective burden of care refers to the external 
stressors that caregivers experience, such as disruptions in family interaction, 
housekeeping, finances, resources and work-related activities (Ow, 2003). 
Definition of Terms: Operational Definitions 
Marwit-Meuser"Caregiver Grief Inventory Childhood Cancer (MM-CGI 
Childh~od Cancer): The MM-CGI Childhood Cancer is a survey used to measure 
personal sacrifice burden, heartfelt sadness and longing, and worry and felt isolation in 
parent caregivers of pediatric oncology patients. The original MM-CGI was developed to 
measure these experiences in caregivers of Alzheimer's patients but was modified by Al-
Gamal et aI. (2009) to measure anticipatory grieving in Jordanian parents of pediatric 
oncology patients "(AI-Gamal et aI., 2009; Marwit & Meuser, 2002; Meuser & Marwit, 
2001). The modified version of the MM~CGI will be used as a quantitative piece to the 
qualitative questionnaire in Table 1. 
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Limitations 
Limitations may include the sample size as well as a sample collection from a 
midwestern hospital only. Lack of cultural diversity and diverse health and treatment 
histories may also be liniitations. In addition, this study' only seeks to interview guardian 
. . . 
caregivers, though other:f~ily members may be able to provide useful insight as well. 
Assumptions 
This study will be growided in the following assumptions: 
1. Guardian caregivers of pediatric oncology patients who have undergone HSCT 
experience caregiver role strain and burden. 
2. Guardian caregivers of pediatric oncology patients who have undergone HSCT 
experience grief. 
3. HSCT treatment affects personal relationships within the family. 
Summary 
Guardian caregivers of pediatric oncology patients that have been treated or will 
be treated with HSCT are atrisk for caregiver role strain and burden. The severity' of the 
disease and the treatment contribute to several emotional, practical, social, and financial 
stressors placed on the caregivers. This study will focus on exploring the subjective and 
objective burden and role strain experienced by these caregivers. 
,- : L' j 
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CHAPTER II 
Introduction 
Guardians are the natural caregivers of their children. However, when a child is 
diagnosed with cancer and faces serious treatments such as HSCT, the guardian caregiver 
, 'is at risk for developing caregiver role strain and burden. The purpose of this study is to 
explore the specific stressors and role strain that guardian caregivers of pediatric 
oncology patients who have undergone HSCT experience. 
Organization of Literature 
The following review of literature consists of selected studies related to caregiver 
role strain and burden. -The first section will provide a brief description of the framework 
'that will guide the theory of coping in this study. The second section will provide a basis 
for general caregiver role strain and burden. The third section will focus on specific 
studies exploririg caregiver role strain in caregivers of oncology patients. 
Theoretical Framework, 
Coping is the "constantly changing cognitive and behavioral efforts to manage 
specific external and/or internal demands that are appraised as taxing or exceeding the 
resources of the person" (Lazarus & Folkman, 1984, p. 141). This theory suggests that 
coping is a process and requires effort on the part of the individual and focuses on "what 
the person actually thinks or does" (Lazarus & Folkman, 1984, p. 142). Stress is defined 
as a "relationship between the person and the environment that is appraised by the person 
as taxing' or exceeding his or her resources and endangering his or her well-being" 
(Lazarus & Folkman, 1984, p. 19). In the stress process, there is primary appraisal, 
where the individual evaluates the stressor for-well being, and secondary appraisal, where 
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the individual evaluates interventions to manage ti:le stressor. Lazarus and Folkman 
(1984) also identified proble~:-focused coping and emotion-focused coping. In problem-
focused coping, the individual implements strategies "directed at managing ,or altering the 
problem causing the distress" (p. 150), whereas emotion-focused coping is "directed at 
.regulating emotional response to the problem" (p. 150). This framework of stress and 
coping can be related to processes of stress and coping in legal guardiari caregivers of 
pediatric oncology patients treated with HSCT. 
General Caregiver Role Strain and Burden 
Caregiver role strain and burden are terms used to describe the feeling of stress 
and overwhelmed that caregivers experience (Fadden et aI., 1987; Herdman (Ed.), 2009; 
, . . 
Honea, Brintnall, Given, Sherwood, Colao, Somers, & Northouse, 2008; Ow, 2003). 
Sanders, Ott, Kelber, and Noonan (2008) focused on the grief component that caregivers 
of Alzheimer's disease and related dementi as (ADRD) experience. The population 
consisted of forty-four spouses and adult children caregivers, and a short-form of the 
MM-CGI (MM-CGI-SF) was administered and revealed seven emerging themes in those 
that experienced high levels of grief. The themes included yearning for the past, regret 
and guilt, isolation, restricted freedom, life stressors, systemic issues, and coping 
strategies. Coping strategies included pets, social supports, and spiritual faith. Further 
quantitative studies revealed that the seven themes were. unique to the caregivers 
experiencing high levels of grief versus those experiencing low to moderate levels of 
grief. Sanders et ai. (2008) suggest that supportive interventions focus on reducing 
feelings of isolation, guilt, loss, and regret while increasing feelings of freedom and 
familiarity with coping strategies. 
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Caregiver Role Strain and Burden in Oncology Population 
Gaugler, Linder, Given,Kataria, Tucker, & Regine (2008) examined indicators of 
emotional stress linked to care that negatjvely impacted caregivers' perceptions of family 
members, finances, and schedules and resources to prevent caregivers from these 
stressors. The sample included 186 caregivers recruited from radiation medicine clinics 
at the University of Maryland Greenebaum Cancer Center (UMGCC) in Baltimore, 
Maryland. Inclusion criteria required that participants consider themselves the primary 
caregivers of the patient. Participants were then divided into two samples. One sample 
was recruited over a year and participated in a cross-sectional study of cancer caregiver 
stress (n = 103), while the other sample participated in a year-long longitudinal study of 
cancer care giving stress arid the stress process (n = 83; summer 2004-2006). 
Demographic data was collected. A five-item sub scale of Caregiver ReaCtion . 
Assessment of Given et al. (2007) ~as used to measure lack of family support (a = .83), 
whereas four-item subscales ofthe same Caregiver Reaction Assessment were used to 
measure finanCiai support (a = .68) and' care provision on the caregiver's schedule (a = 
.67) (Given, Givep, Stommel, Collins, King, &Franklin, 2007). Subscale responses 
ranged from 1 = "strongly agree" to 5 = "strongly disagree." The researchers concluded 
that caregivers who worked had less financial strain, and those who were older or of 
greater income had less scheduling strains and more family ~upport. 
. -
Primary objective stressors were measured through examining the extent of help 
required to perform activities of daily living (ADLs) such as bathing, dressing, and eating 
. . 
(a = .80) and instrumental activities of daily living (IADLs) such as shopping, 
housework, and finances (a = .84). Responses ranged from 0 = "no help," to 1 = "some 
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help," and 2 = "a lot of help." Results concluded that those who cared for patients with 
great ADL dependency were more likely to e~peri~nce a lack of family support, whereas 
the opposite was true for those who cared for patients with great IADL dependency. 
Gaugler et aI. (2008) also' explored involuntary aspects of the caregiving role (a = 
.77), role overload (a = .82), and feelings of emotional and physical separation from the ) '. . 
patient (a:::;: .84) using a set of three-item subscales measuring primary subjective 
stressors (Perlin, Mullan, Semple, & Skaff, 1990). Primary subjective stressors were 
predictors of secondary stress. Greater role overload resulted· in scheduling stress, 
financial burden, lack of family support, and loss of intimacy with· the receiver of care. 
An addi.tionaleight-item measure assessed cohesion within the caregiver's social network 
(a = .91) and found that those who indicated optimism for care were less likely to 
indicate it lack of familial support. Socioemotional support appeared to help alleviate 
secondary stress, financial stress, scheduling stress, and family tension (Gaugler et aI., 
2008). 
Ow (2003) investigated subjective and objective burden of care in Asian parents 
of pediatric oncology patients. A questionnaire was developed and conducted face-to-
face to thirty-two participants from twenty-eight families within three months of the 
child's diagnosis (Tl) and again three to six months after diagnosis (T2). Due to death, 
lack of interest in the study, and relapse, 1'2 consisted of twenty-two participants from 
twenty families. Questions in Ti included "What wa~ your first reaction to the diagnosis 
of your child?" "Do you feel there is an explanation for your child's illness?" "If yes, 
what do you think it is? Please describe." "Are both you and your spouse working? If 
yes, how did you manage with work, looking after the home ad the ill child at the same 
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time?" "Are you satisfied with the current arrangements?" "If yes, why? If not, what 
were the problems encountered?" "If there are other children, who looks after them when 
the ill child is in the hospital?" (Ow, 2003). The investigator found that distress among 
the parents was reported as high and included fear (n = 5), worry (n =.7), sadness (n = 7), 
shock, disbelief, and lack of acceptance (n = 13), sense of hopelessness (n = 3), and guilt 
(n = 6) - all indicators of subjective burden. Objective burden was a secondary priority 
to these caregivers at Tl (Ow, 2003). 
Questions in T2 included "Since the first interview, are there any changes to your 
feelings to the diagnosis of the illness?"· "What do you now feel is the explanation for 
your child's illness?" "Are there any changes to what you first thought?" "If yes, how 
did these changes come about?" "Do you tend to seek more information about your 
child's illness? If yes, what kind of information?" "Was it easy to communicate with 
doctors, nurses, and social workers about what you need to know? If yes, what helped? 
If not, why?" "Besides professionals in the hospital, did you talk to other people to help 
. . 
you understand your child's illness? If yes, what questions did you ask them?" (Ow, 
2003). At T2, personal emotional need; an indicator of subjective burden remained a top 
priprity for caregivers followed by a need for informational resoutces. This need evolved 
because the diagnosis still was perceived as threatening to the family, particularly in 
patients who were not responding well to treatment. Also, contact with medical 
professionals and social workers decreased with time, reflecting the parents' increased 
need for information. Objective burden of care decreased over time following the initial 
hospitalization period for the child. 
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Summary 
Several factors influence the degree to which a guardian caregiver experiences 
strain and burderi. Quantitative and qualitativ~ approaches have been used to study these 
influences as well as to identify specific stressors. However~ ~her research -is needed to 
explore the specific impact of HSCT on guardian caregivers of pediatric oncology 
patients. 
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CI-{AJ>TER III 
Introduction 
A three-part study measuring demographic information, qualitative data, and 
quantitative data will be conducted to examine caregiver role strain and burden in 
I 
gUilldian caregivers of pediatric oncology patients treated with HSCt. 
Research Question 
23 
• To what degree do guardian caregivers feel as though the caregiver role has resulted 
in personal sacrifice burden? Heartfelt sadness and longing? Worry and isolation? 
• What is the'total grief level of guardian caregivers? .' 
• What specific stressors,has HSCT placed on the guardian caregivers? family? 
• ,How has HSCT affected personal relationships within the family? 
Population, Sample and Setting 
. .. 
A convenience sample of eight to ten guardian sets is recommended from a 
, " ,-
Midwestern hospital. The guardian se~s must be twenty years of age or older, male or 
female, and single,' married, divorced, or widowed. 
Protection of Human Subjects 
This study should be submitted to both university Institutional Review Board (if 
applicable) and to the facility'sInstitutional Review Board where the study will be 
conducted. The participants would be in~luded on a voluntary basis only. A cover ietter 
addressing the purpose of the study, the purpose of the questionnaire, and a statement 
explaining that their identities will remain anonymous at all times would be included and 
explained. Informed consent would be obtained. The infoimed consents, demographic 
information, questionnaire responses, arid voice recordings will be treated as confidential 
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and keptin a locked container with access limited to the investigator. Identified risks 
would be minimal, butmay involve an em?tional response from the participant from 
speaking about hisllier child's condition and/or how it has affected himlher and/or hislher 
family. 
Procedure 
Upon receiving permission from the appropriate Institutional Review Boards, the 
researcher will post a flier in a well-trafficked area on the unit with an explanation of the 
purpose of the study and the resear.cher's contact information if interested. Once the 
researcher is contacted through a secure connection, the researcher should interview the 
potential participant to ensure that he/she qualifies to participate in the study and to verify 
interest. When "qualification and interest has been verified, the researcher should 
schedule a time to conduct the study. Immediately before the study commences, the 
researcher should provide the cover letter addressing the purpose' of the study, the 
purpose of the questionnaire; and statement explaining that their identities will remain 
anonymous at all times and explain and obtain all informed consent. 
The researcher should then begin the study by having the guardian(s) complete a 
foim addressing demographic information (Form 1). Upon completion of this form, the 
researcher should begin the qualitative portion of the study by recording the interview 
questions and anSwers addressed inTable 1, ensUring enough time for the participant(s) 
to fully share their answers. Once the qualitative portion of the study is complete, the 
researcher should have the guardian(s) complete the Modified MM-CGI. When this 
questionnaire is complete, the researcher should thank the participant(s) andoffer 
information about additional resources if requested. This process should be repeated 
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until the qualitative information is saturated with repetition of themes in participant 
responses. 
Instrumentation, Reliability and Validity 
The researcher should begin by encouraging the participants to provide the 
demographic and background information in Form 1. This form identifies the patient's 
diagnosis and treatment history, the caregiver's relationship to the. patient, general 
income information, and additional children information. Table 1 provides the 
qualitative questions that t4e investigator should explore with the participants. To ensure 
reliability and validity, the investigator must develop a coding system upon replaying the 
interviews and proceed with further interviews until all of the information has been 
saturation and themes have been repeated. The final instrument is the MM-CGI 
Childhood Cancer and will provide complimentary quantitative data. Al-Gamal et al. 
(2009) developed a modified version of the MM-CGI to measure anticipatory grieving in 
Jordanian parents of pediatric oncology patients called. the MM-CGI Childhood Cancer 
and shows great promise in measuring the burden of grief (subjective burden) in 
caregivers of pediatric oncology patients tr~ated with HSCT. The fifty-item tool with 
some reverse coding and a five-point Likert-type response format (l = "strongly 
disagree" to 5 = "strongly -agree") measures personal sacrifice burden, heartfelt sadness 
and longing, and worry and felt isolation. In 2006, the-tool was administered fo 140 
Jordanian parents living with a child with cancer. The Cronbach a. coefficient for the 
total instrument was 195, and the Cronbach a. coefficients for each of the three subscales 
was .91 for personal sacrifice burden, .90 for heartfelt sadrtess and longing, and .86 for 
worry and felt isolati()n (Al-Gamal et aI., 2009). The validity of the instrument was 
RUNNING HEAD: Caregiver Strain Burden in Parents 26 
supported by the demonstration of a positive correlation to the Anticipatory Grief Scale 
(Levy,1991). Due to the use oftheiilstrurnent with a qualitative piece, the MM-CGI 
. Childhood Cancer should be examined for further internal cqnsistency using the 
Cronbach a coefficient with a smaller sample size~ 
,. I 
. Research Design 
This is. an exploratory descriptive study because three different measurement 
pieces will be used to collect data: the demographic and background information form, 
the qualitative research interview questions, and the quantitative MM-CGI Childhood 
Cancer. Triangulation will be used t6 cross-examine the results of the data. 
Data Analysis 
For the qualitative portion of the study, the investigator must develop a coding 
system to identify common themes shared in the participant interviews. Descriptive 
statistics will be used to measure the Tesults of the MM-CGI Childhood Cancer with the 
Cronbach a coefficient measuring for internal consistency. Once all of the demographic 
data (Form 1), qualitative data (Table 1), and quantitative data (MM-CGI Childhood 
Cancer) have been collected, the chi-square statistical test will be used to deterrrtine 
whether there is a significant relationship among the data (Cozby, 2009).' 
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Summary 
Caregiver role strain and burden is a significant risk in guardian caregivers of 
pediatric oncology patients treated with HSCT. The severity ofthe illness and the care 
required for the pediatric oncology patient who has received HSCT can be overwhelming 
for caregivers and deserves examination on the part of the health care provider. Through 
exploring the relationship among demographic data, qualitative data, and quantitative 
data, the investigator is able to identify specific stressors and areas of burden for 
caregivers .. A plan specific to the guardian caregivers can then be created to alleviate 
these stressors and provide needed resources. 
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Forni 1: Demographic and Background Information 
Participant #: 
Child's information 
Child's Age': ______ Child's Current Grade in School ___ _ Child's sex: M F 
Race/ethnicity: 
What is your child's diagnosis?_.,----,:---_____ :-------:_" 
Has your child received hematopoietic stem cell transplantation? Y __ N __ 
Ifyes, when? ___ '--,-__ 
If no, when will he/she receive it? 
:-------:-::--:-c:--~ 
Please indicate whether your child has received the following treatments: 
Proced ure/Treatm ent 
Surgery? 
Chemotherapy? 
Radiation? 
Y _'_ N__ If yes, what procedure? ____ ----, ___ _ 
Y N If yes, how many rounds? _____ ---,-__ _ 
Y === N=== If yes, how many rounds? _______ _ 
To what area(s)? _______ ~ __ _ 
Other? Y __ N __ Explain ______________ _ 
Guardians'information 
Number of Guardian Caregivers in Interview: 
Relationship status to each other (ifapplicabI6): ____________ ~ 
Relationship status to child (receiver of care): ____________ _ 
Estimated annual income (check one): 
__ 1. < $15,000 
_ 2. $15,000-24,999 
_ 3. $25,000~34,999 
_ 4. $35,000-44,999 
_ 5. $45,000-54,999 
6. $55,000-64,999 
_6; $65,000-99,999 
_6. >$100,000 ' 
Guardian Caregiver I Information 
Age: Employment"Status: ____ _ 
Highest level of education completed (check one): 
Guardian Caregiver 2 Information 
Age: 'Employment Status: ___ _ 
__ 11. Some high school __ 1. Some high school 
__ 2. Completed high school __ 2. Completed high school 
__ 3. Some college _,_" 3. Some coliege 
_" _ 4. 2-year degree __ 4. 2-year degree 
__ 5. 4-year degree ' __ 5. 4-year degree 
__ 6. Graduatedegree __ 6. Graduate degree 
Are there other children in the household? Y __ N __ If yes, what are their ages? ____ _ 
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Table 1: Qualitative Questions 
1. Tell me about your initial feelings when you first learned of your child's 
diagnosis. 
32 
2. How many hours a day would you say that you spend thinking about your child's 
diagnosis? 
3. What is it like watching your child go through treatment? 
4. How has your child's diagnosis and treatment affected your family dynamic? 
Your romantic relationship/marriage? Relationship with your other children? 
. Relationship between your child and his/her siblings? 
5. How has your child's diagnosis and treatment affected your relationship you're 
your other support systems (i.e. extended family, friendships)? 
6. How has your child's diagnosis and treatment affected your work/career? Leisure 
activities? 
7. How has your child's diagnosis and treatment affected your personal health? 
8. How has your child's diagnosis and treatment affected your caregiving 
responsibilities as a parent? 
9. How does the process involved in stem cell transplantation" compare with other 
treatments that yqur child has receive'd? 
10. Tell me about feelings that you currently have about transplantation and any 
additional ways it has affected your life. " 
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MM Caregiver Grief Inventory Childhood Cancer 
Original MM-CGI Created by: 
Thomas M. Meuser, Ph.D., Washington University, St. Louis 
Samuel 1. Marwit, Ph.p., University of Missouri-St. Louis 
John Chibnall, Ph.D., St. Louis University School of Medicine 
Modifications by: 
Ekhlas Al-Gamal, BSc, MSc, RN 
Tony Long, BSc, MA, PhD, RN 
Loan Livesley, BSc, MA, RN 
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Instructions: This inventory is designed to measure the grief experience of current 
family caregivers of persons living with progressive dementia (e.g., Alzheimer's disease), 
but it has been modified to address the grief of caregivers of pediatric oncology patients. 
Read each statement carefully, and then decide how much you agree or disagree with 
what is stated. 
Circle a number 1-5.to the right using the answer key below (For example 5 = Strongly 
Agree). It is important that you respond to all items so that the scores are accurate. 
Scoring rules are listed at the end. 
ANSWER KEY 
1 = Strongly Disagree; 2 == Disagree; 3 = Somewhat Agree; 4 = Agree; 5 = Strongly Agree 
1 I'.ve had to give up a great deal to care formy child since 1 2 3 4 5 
diagnosis. 
2 I miss so many of the activities I used to share with my 
. . 
1 2 3 4 5 
child since the diagnosis Was made. 
3 I feel I am losing my freedom. 1 2 3 4 5 
4 My physical health has declined from the stress ·of being a 1 2 3 4 5 
caregIver. 
S I have nobody to communicate with. 1 2 3 4 5 
6 I don't know what is happening. I feel confused and 1 2 3 4 5 
, 
unsure. 
7 I carry a lot of stress caring for my child since the 1 2 3 4 5 
diagnosis was made. 
8 I receive enough emotional support from others. 1 2 3 4 5 
9 I have this empty, sick feeling knowing that my child was 1 2 3 4 5 
diagnosed with this illness. 
10 I feel anxious and scared. 1 2 3 4 5 
11 Mypersonallife has changed a great deal. 1 2 3 4 5 
12 I spend a lot of time worrying about the bad things to 1 . 2 3 4 5 
come. 
13 This diagnosis is like a double loss .. .I've lost the 1 2 3 4 5 
closeness with my child an,d connectedness with my 
family. 
A 
B 
A 
A 
C 
C 
A 
Cr 
B 
C 
A 
C 
C 
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1.4 I feel terrific sadness. 1 2 3 4 5 B 
15 The diagnosis of my child with this illne~s is totally 1 2 3 4 5 B 
unacceptable iIi my heart. 
16 My friends simply don't Wlderstand what I'm going 1 2 3 4 5 C 
through. 
17 I feel this constant sense of responsibility and it just never 1 2 3 4 5 A 
leaves. 
18 I long for what was, what we had and shared in the past 1 2 3 4 5 B 
19 I could deal with other serious treatments better than with 1 2 3 4 5 B 
this. 
20 I can't feel free in this situation. 1 2 3 4 5 A 
21 Since the diagnosis I'm having trouble sleeping. 1 2 3 4 5 A 
22 I'm at peace with myself and my situation in life. , 1 2 3 4 5 Cr 
23 I know we'll get through it 1 2 3 4 5 Cr 
24 My extended family has no idea what i 'go through in 1 2 3 4 5 C 
caring for himlher. 
25 I feel so frustrated that I often tune my child's diagnosis 1 2 3 4 5 A 
out.' 
26 I am always worrying. 1 2 3 4 5 C 
27 I'm angry at the disease for rubbing me of so much. 1 2 3 4 5 B 
28 This is requiring mOre emotional energy and 1 2 3 4 5 A 
determination than I ever expected. 
29 I will be tied up with this for who knows how long. 1 2 3 4 5 A 
30 It hurts to put"my child in bed at night knowing that that 1 2 3 4 5 B 
shelhe is diagnosed wIth this illness. 
31 I feel very sad about what this disease has done. 1 2 3 4 5 B 
32 I feel severe depression. 1 2 3 4 5 C 
33 I lay awake most nights worrying about what's happening 1 2 3 4 5 C 
and how I'll manage tomorrow. 
34 The people closest t6 me do not understand what I'm 1 2 3 4 5 C 
going through. 
35 My child's recovery will bring me renewed per~onal 1 2 3 4 5 A 
freedom to live my life. 
36 I feel powerless since my child's diagnosis. 1 2 3 4 5 B 
37 . It's frigh~enin:g beca\lse you don't know if doctors can 1 2 3 4 5 B 
cure this disease, so things 'may only get worse. 
38 The losses I'm experiencing since my child's diagnosis 1 2 3 4 5 B 
are much more troubling than any I've experienced 
before. 
39 Independence is what I've lost.. . since my child's 1 2 3 4 5 A 
diagnosisI don't have the freedom to go anddo what I 
. want. 
40 I've had to make some drastic changes in my life as a 1 2 3 4 5 A 
result of becoming a caregiver. 
41 I wish I had an hour or two to myself each day to pUrsue 1 2 3 4 5 A 
... 
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personal interests. 
42 I'm stuck in this caregiving wofld and there's nothing I 1 2 3 4 5 
can do about it. 
43 I can't contain mY,sadness about all that's happening. 1 2 3 4 5 
44 What upsets me most is what I've had to give up. 1 2 3 4 5 
45 I'm managing pretty well,overall. 1 2 3 4 5 
46 I think I'm denying the full implications of this for my" 1 2 3 4 5 
life. 
47 I get excellent support' from members of my family, 1 2 3" 4 5 
48 I've had a hard time accepting what is happening. 1 2 3 4 5 
49 The demands on me are growing faster than I ever 1 2 3 4 5 
expected. 
50 I wish this was all a dream and I could wake up back in 1 '2 3 4 5 
myoId life. 
Self-Scoring Procedure: Add the numbers ypu circled to derive the following sub-scale 
and total grief scores. Use the letters,to the right of each score to guide you. C Items 
with Hr" afterwards must first be reverse scored (1 changed to 5, 2 changed to 4, 3 
changed to 3, 4 changed to 2, 5, changed to 1) before adding to calculate your scores. 
Personal Sacrifice Burden (A Items) = ___ ---,-
(18 Items, M = 54.3, SD = 14.1, Alpha = .93,Spli~-Ha:lf= .91) 
Heartfelt Sadness & Longing (B Items) = ___ _ 
(15 Items, M = 48.2, SD = 11.1, Alpha = .90, Split-Half= .86) 
Worry & Felt Isolation (C Items) = ___ _ 
(17 Items, M = 40.6, SD = 11.9, Alpha = .91, Split-Half= .91) 
Total Grief Level (Sum A + B + C) = ___ _ 
(50 Items, M = 144, SD = 31.6, Alpha = .96, Split-Half= .87) 
Plot your scores using the grid on the following page. Make an "X" in the "shaded 
section nearest to your numer~c score for each sub-scale. This is your grief profile. 
Discuss this profile with your nurse. ' 
A 
B 
A 
Cr 
C" 
Cr 
B 
A 
B 
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MM-CGI, Personal'Gr:ief Profile 
1 
90 : 
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o 
Personal Sacrifice Heartfelt Sadness 
Burden & Longing 
What do these- sc-ores mean? 
Worry & 
F ell' Isolation 
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HIGH 
AV 
LOW 
Scores in the top area are higher than average based validation sample 
statistics (1 SD above the Mean}. High scores may indicate a need for 
formal':interve:ntion or support assistance to enhance coping. Low scores 
in the bottom lined section (1 SO'below the Mean) may indicate denial or 
a downplaying' of distress. Low scores may also indicate' positive 
adaptation if the individual is not showing other signs of suppressed 
grief. Average ~cores' in the center:indicate common reactions. These 
are general guides for discus:sionandsupportonly -more research is 
needed on more specific interriretation issues. 
. , 
